Thread 🧵

1/ Next Generation Protein Sequencing - $CAPA $QSI

I often see investors making miscalculated risks in genomics. The main mistake I see is investors trying to play catch up and chasing the most popular names today.

The best way to make calculated risks is identifying tomorrow's big names. Right now, there's a major lack of attention being paid to Next Generation Single Molecule Protein Sequencing. In this case, I'm specifically talking about $CAPA.

What makes this company avant-garde and why should we be paying attention? The current approaches in proteomics have major drawbacks.

The problem with affinity assays is that they're biased tests where the only thing that will be found is what you can test for.

MS is the gold standard for protein analysis. However, MS requires enough homogenous sample to fill its chamber which is roughly about 1,000,000 molecules. This is severely limiting, especially in instances where we need to identify antigens expressed on a tumor sample.

While RNA has become a popular approach for protein analysis, there is ongoing debate about its direct measurement with protein expression.

Next Generation Single Molecule Protein Sequencing like $CAPA can intervene here by helping researchers get a better understanding of what, when, where and why certain markers are being expressed.

The most lucrative opportunity comes in neurological applications and CNS diseases. Many associated conditions like Alzheimer’s, ALS, and Parkinson’s, for example, are disorders of post-translational modifications, specifically phosphorylation.

MS and RNA sequencing fall short in their ability to detect post-translational modifications.

It is my opinion that $CAPA will usher in a new era of novel therapeutic medicines for mankind's most cryptic and challenging conditions.

I'm betting that within the decade, $CAPA's Platinum and Carbon machines will be a fixture in Labs/Universities all across the country.

End Thread.

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Nat Harooni 🧬

Nat Harooni 🧬 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @NatHarooni

1 May
Are there any FinTwit accounts that you associate with one particular stock due to their unwavering and rock solid conviction?
@BahamaBen9 and $RDFN has some of the strongest support on this platform IMO. Really cool to see
@DisruptorStocks done buying stocks. Accumulating lumber in his garage
Read 4 tweets
30 Apr
Listening to Brad Loncar's podcast on CRISPR right now. I respect the man but I will unapologetically disagree when people call CRISPR outdated compared to Base Editing. These are 1A and 1B to each other for the foreseeable future.…
On the point of double stranded breaks, Cas9 has been engineered by nature over the course of millions of years. Often times, there is no better engineer than nature. There people more talented than you and me working around the clock to optimize CRISPR-Cas.
This may be over simplifying it but it's a useful analogy. When I hear people compare CRISPR-Cas to Cytosine Deaminase Base Editors, its like comparing a scissor to a pencil. The two are exceptionally good at their own utilities, so why compare apples to oranges?
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!